Sentinel Lymph Node Technique for Staging of Breast Cancer

Area of Science:

• Oncology
• Surgical Pathology
• Medical Imaging

Background:

• Axillary lymph node status is critical for breast cancer staging and treatment decisions.
• Traditional axillary lymph node dissection carries significant morbidity (15-20% complication rate).
• Sentinel lymphadenectomy offers a less invasive alternative for assessing nodal involvement.

Purpose of the Study:

• To evaluate the efficacy and safety of lymphatic mapping and sentinel lymphadenectomy in breast cancer staging.
• To compare the complication rates of sentinel lymphadenectomy with axillary lymph node dissection.
• To explore the potential of sentinel lymph node analysis for improved metastasis detection.

Main Methods:

• Intraoperative lymphatic mapping using vital blue dye and/or radioactive tracer.
• Excision of the sentinel lymph node for histopathologic analysis.
• Utilizing sensitive immunohistochemical techniques and reverse transcriptase polymerase chain reaction for metastasis detection.

Main Results:

• Sentinel lymphadenectomy can be successfully performed in over 90% of cases by experienced surgeons.
• The morbidity associated with sentinel lymphadenectomy is minimal compared to axillary lymph node dissection.
• Sentinel node analysis allows for detailed histopathologic examination and molecular studies.
• Sentinel node detection rates exceed 90% using either vital blue dye or radioactive tracer, or both.

Conclusions:

• Sentinel lymphadenectomy is a safe and effective technique for assessing axillary status in breast cancer.
• It significantly reduces complications compared to traditional axillary lymph node dissection.
• The technique provides enhanced diagnostic capabilities for detecting micrometastases.
• Currently considered an experimental staging adjunct, further follow-up data are needed to establish its therapeutic role.